| Year |
Citation |
Score |
| 2023 |
Rudd MT, Manley PJ, Hanney B, Meng Z, Shu Y, de Leon P, Frie JL, Han Y, Wai JM, Yang ZQ, Perkins JJ, Hurzy DM, Manikowski JJ, Zhu H, Bungard CJ, ... Converso A, et al. Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric Modulator. Acs Medicinal Chemistry Letters. 14: 1088-1094. PMID 37583812 DOI: 10.1021/acsmedchemlett.3c00210 |
0.282 |
|
| 2023 |
Wang C, Adam GC, Burlein C, Carroll S, Dankulich W, Diamond T, Grobler J, Heath J, Johnson A, Klein D, Krosky D, Narayan K, Ou Y, Sanders J, Sharma S, ... ... Converso A, et al. Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activity. Bioorganic & Medicinal Chemistry Letters. 129303. PMID 37146837 DOI: 10.1016/j.bmcl.2023.129303 |
0.344 |
|
| 2023 |
Balibar CJ, Klein DJ, Zamlynny B, Diamond TL, Fang Z, Cheney CA, Kristoff J, Lu M, Bukhtiyarova M, Ou Y, Xu M, Ba L, Carroll SS, El Marrouni A, Fay JF, ... ... Converso A, et al. Potent targeted activator of cell kill molecules eliminate cells expressing HIV-1. Science Translational Medicine. 15: eabn2038. PMID 36812345 DOI: 10.1126/scitranslmed.abn2038 |
0.27 |
|
| 2022 |
Moore KP, Schwaid AG, Tudor M, Park S, Beshore DC, Converso A, Shipe WD, Anand R, Lan P, Moningka R, Rothman DM, Sun W, Chi A, Cornella-Taracido I, Adam GC, et al. A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells. Acs Chemical Biology. PMID 36044633 DOI: 10.1021/acschembio.2c00515 |
0.268 |
|
| 2022 |
Wuelfing WP, El Marrouni A, Lipert MP, Daublain P, Kesisoglou F, Converso A, Templeton AC. Dose Number as a Tool to Guide Lead Optimization for Orally Bioavailable Compounds in Drug Discovery. Journal of Medicinal Chemistry. PMID 35060378 DOI: 10.1021/acs.jmedchem.1c01687 |
0.257 |
|
| 2020 |
Yan XC, Sanders J, Gao YD, Tudor M, Haidle AM, Klein DJ, Converso A, Lesburg CA, Zang Y, Wood HB. Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery. Journal of Chemical Information and Modeling. PMID 32309939 DOI: 10.1021/Acs.Jcim.0C00113 |
0.361 |
|
| 2020 |
Shu Y, Diamond TL, Hershey JC, Huang S, Magliaro BC, O'Brien JA, Schlegel KS, Puri V, Uebele VN, Uslaner JM, Wang C, Converso A. Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models. Bioorganic & Medicinal Chemistry Letters. 127066. PMID 32173198 DOI: 10.1016/J.Bmcl.2020.127066 |
0.347 |
|
| 2018 |
ElMarrouni A, Suen L, Wang C, Hunter D, Mitchell H, Converso A. Synthesis of HIV NNRTI Doravirine Analogues via Visible-Light Photoredox Decarboxylative Cross-Coupling Synthesis. 50: 3177-3186. DOI: 10.1055/S-0037-1610155 |
0.657 |
|
| 2017 |
Burlein C, Wang C, Min X, Bhatt T, Stahlhut M, Ou Y, Adam GC, Heath J, Klein DJ, Sanders J, Narayan K, Abeywickrema P, Heo MR, Carroll SS, Grobler JA, ... ... Converso A, et al. Discovery of a Distinct Chemical and Mechanistic Class of Allosteric HIV-1 Integrase Inhibitors with Antiretroviral Activity. Acs Chemical Biology. PMID 29024587 DOI: 10.1021/Acschembio.7B00550 |
0.422 |
|
| 2017 |
ElMarrouni A, Campbell M, Perkins JJ, Converso A. Development of a sp(2)-sp(3) Stille Cross-Coupling for Rapid Synthesis of HIV NNRTI Doravirine Analogues. Organic Letters. PMID 28589720 DOI: 10.1021/Acs.Orglett.7B01142 |
0.486 |
|
| 2016 |
Finley M, Cassaday J, Kreamer T, Li X, Solly K, O'Donnell G, Clements M, Converso A, Cook S, Daley C, Kraus R, Lai MT, Layton M, Lemaire W, Staas D, et al. Kinetic Analysis of Membrane Potential Dye Response to NaV1.7 Channel Activation Identifies Antagonists with Pharmacological Selectivity against NaV1.5. Journal of Biomolecular Screening. PMID 26861708 DOI: 10.1177/1087057116629669 |
0.348 |
|
| 2014 |
Converso A, Hartingh T, Fraley ME, Garbaccio RM, Hartman GD, Huang SY, Majercak JM, McCampbell A, Na SJ, Ray WJ, Savage MJ, Wolffe C, Yeh S, Yu Y, White R, et al. Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase. Bioorganic & Medicinal Chemistry Letters. 24: 2737-40. PMID 24813734 DOI: 10.1016/J.Bmcl.2014.04.034 |
0.355 |
|
| 2011 |
Vardigan JD, Converso A, Hutson PH, Uslaner JM. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task. Journal of Neurogenetics. 25: 120-6. PMID 22070409 DOI: 10.3109/01677063.2011.630494 |
0.364 |
|
| 2011 |
Hutson PH, Finger EN, Magliaro BC, Smith SM, Converso A, Sanderson PE, Mullins D, Hyde LA, Eschle BK, Turnbull Z, Sloan H, Guzzi M, Zhang X, Wang A, Rindgen D, et al. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents. Neuropharmacology. 61: 665-76. PMID 21619887 DOI: 10.1016/J.Neuropharm.2011.05.009 |
0.366 |
|
| 2009 |
Converso A, Hartingh T, Garbaccio RM, Tasber E, Rickert K, Fraley ME, Yan Y, Kreatsoulas C, Stirdivant S, Drakas B, Walsh ES, Hamilton K, Buser CA, Mao X, Abrams MT, et al. Development of thioquinazolinones, allosteric Chk1 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19: 1240-4. PMID 19155174 DOI: 10.1016/J.Bmcl.2008.12.076 |
0.36 |
|
| 2006 |
Díaz DD, Converso A, Sharpless KB, Finn MG. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: multigram display of azide and cyanide components on a versatile scaffold. Molecules (Basel, Switzerland). 11: 212-8. PMID 17962753 DOI: 10.3390/11040212 |
0.62 |
|
| 2005 |
Nicolaou KC, Sasmal PK, Koftis TV, Converso A, Loizidou E, Kaiser F, Roecker AJ, Dellios CC, Sun XW, Petrovic G. Studies toward the synthesis of azadirachtin, part 2: construction of fully functionalized ABCD ring frameworks and unusual intramolecular reactions induced by close-proximity effects. Angewandte Chemie (International Ed. in English). 44: 3447-52. PMID 15849805 DOI: 10.1002/Anie.200500217 |
0.646 |
|
| 2005 |
Nicolaou KC, Sasmal PK, Roecker AJ, Sun XW, Mandal S, Converso A. Studies toward the synthesis of azadirachtin, part 1: total synthesis of a fully functionalized ABC ring framework and coupling with a norbornene domain. Angewandte Chemie (International Ed. in English). 44: 3443-7. PMID 15846829 DOI: 10.1002/Anie.200500216 |
0.685 |
|
| 2004 |
Converso A, Saaidi PL, Sharpless KB, Finn MG. Nucleophilic substitution by grignard reagents on sulfur mustards. The Journal of Organic Chemistry. 69: 7336-9. PMID 15471488 DOI: 10.1021/Jo0489869 |
0.609 |
|
| 2001 |
Converso A, Burow K, Marzinzik A, Sharpless KB, Finn MG. 2,6-Dichloro-9-thiabicyclo[3.3.1]nonane: a privileged, bivalent scaffold for the display of nucleophilic components. The Journal of Organic Chemistry. 66: 4386-92. PMID 11397181 DOI: 10.1021/Jo015632Y |
0.603 |
|
| 2001 |
Colacino E, Converso A, Liguori A, Napoli A, Siciliano C, Sindona G. Simple and efficient routes for the preparation of isoxazolidinyl nucleosides containing cytosine and 5-methyl-cytosine as new potential anti-HIV drugs Tetrahedron. 57: 8551-8557. DOI: 10.1016/S0040-4020(01)00813-4 |
0.466 |
|
| 2000 |
Sanghvi YS, Guo Z, Pfundheller aHM, Converso A. Improved Process for the Preparation of Nucleosidic Phosphoramidites Using a Safer and Cheaper Activator Organic Process Research & Development. 4: 175-181. DOI: 10.1021/Op990086K |
0.431 |
|
| 1999 |
Colacino E, Converso A, De Nino A, Leggio A, Liguori A, Maiuolo L, Napoli A, Procopio A, Siciliano C, Sindona G. Synthesis of isoxazolidino analogues of 2',3'-dideoxynucleosides. Nucleosides & Nucleotides. 18: 581-3. PMID 10432650 DOI: 10.1080/15257779908041501 |
0.458 |
|
| 1999 |
Adolfsson H, Converso A, Sharpless KB. Comparison of amine additives most effective in the new methyltrioxorhenium-catalyzed epoxidation process Tetrahedron Letters. 40: 3991-3994. DOI: 10.1016/S0040-4039(99)00661-9 |
0.549 |
|
| Show low-probability matches. |